Market overview
The global flow cytometry market is worth USD 5.7 bn in 2026 and is forecast to reach USD 11.8 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Reagents and consumables is the largest by product segment.
| Scope | Instruments, reagents, consumables, software and services for flow cytometry, which counts and sorts cells by light scatter and fluorescence, sold to research labs, hospitals, pharma and biotech. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 5.3 bn |
| Value 2026 | USD 5.7 bn |
| Value 2036 | USD 11.8 bn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 961 million tests |
| Volume 2036 | 1,792 million tests |
| Average price 2026 | USD 5.95 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Flow Cytometry market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 5.7 bn |
| 2027 | USD 6.1 bn |
| 2028 | USD 6.6 bn |
| 2029 | USD 7.1 bn |
| 2030 | USD 7.6 bn |
| 2031 | USD 8.2 bn |
| 2032 | USD 8.8 bn |
| 2033 | USD 9.5 bn |
| 2034 | USD 10.2 bn |
| 2035 | USD 11.0 bn |
| 2036 | USD 11.8 bn |
Flow Cytometry market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Reagents and consumables | 52.0% | 52.9% | USD 3.0 bn | 7.7% |
| Instruments | 32.0% | 29.7% | USD 1.8 bn | 6.7% |
| Software | 8.0% | 9.5% | USD 457 mn | 9.4% |
| Services | 8.0% | 7.9% | USD 457 mn | 7.4% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Research and drug discovery | 44.0% | 42.0% | USD 2.5 bn | 7.0% |
| Clinical diagnostics | 34.0% | 33.7% | USD 1.9 bn | 7.4% |
| Cell and gene therapy | 12.0% | 15.9% | USD 686 mn | 10.6% |
| Industrial and other | 10.0% | 8.4% | USD 571 mn | 5.6% |
By instrument technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Conventional analysers | 52.0% | 46.0% | USD 3.0 bn | 6.2% |
| Spectral analysers | 14.0% | 22.0% | USD 800 mn | 12.5% |
| Imaging cytometers | 10.0% | 10.0% | USD 571 mn | 7.5% |
| Cell sorters | 24.0% | 22.0% | USD 1.4 bn | 6.6% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Academic and research institutes | 30.0% | 28.0% | USD 1.7 bn | 6.8% |
| Pharma and biotech | 28.0% | 29.0% | USD 1.6 bn | 7.9% |
| Hospitals and clinical laboratories | 26.0% | 26.0% | USD 1.5 bn | 7.5% |
| Contract research organisations | 16.0% | 17.0% | USD 914 mn | 8.2% |
By parameter capacity
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Low parameter | 20.0% | 12.0% | USD 1.1 bn | 2.1% |
| Mid parameter | 46.0% | 42.0% | USD 2.6 bn | 6.5% |
| High parameter | 34.0% | 46.0% | USD 1.9 bn | 10.8% |
Top 25 countries for flow cytometry by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 2.2 bn | 38.0% | USD 4.3 bn | 7.0% |
| 2 | China | USD 743 mn | 13.0% | USD 2.0 bn | 10.2% |
| 3 | Germany | USD 400 mn | 7.0% | USD 730 mn | 6.2% |
| 4 | Japan | USD 343 mn | 6.0% | USD 589 mn | 5.6% |
| 5 | United Kingdom | USD 286 mn | 5.0% | USD 542 mn | 6.6% |
| 6 | France | USD 229 mn | 4.0% | USD 412 mn | 6.1% |
| 7 | Canada | USD 171 mn | 3.0% | USD 330 mn | 6.8% |
| 8 | South Korea | USD 171 mn | 3.0% | USD 377 mn | 8.2% |
| 9 | Italy | USD 143 mn | 2.5% | USD 259 mn | 6.1% |
| 10 | India | USD 143 mn | 2.5% | USD 412 mn | 11.2% |
| 11 | Spain | USD 70 mn | 1.2% | USD 139 mn | 7.1% |
| 12 | Australia | USD 70 mn | 1.2% | USD 139 mn | 7.1% |
| 13 | Brazil | USD 60 mn | 1.1% | USD 148 mn | 9.5% |
| 14 | Netherlands | USD 50 mn | 0.9% | USD 99 mn | 7.1% |
| 15 | Switzerland | USD 50 mn | 0.9% | USD 99 mn | 7.1% |
| 16 | Taiwan | USD 50 mn | 0.9% | USD 99 mn | 7.1% |
| 17 | Mexico | USD 40 mn | 0.7% | USD 99 mn | 9.5% |
| 18 | Belgium | USD 40 mn | 0.7% | USD 79 mn | 7.0% |
| 19 | Sweden | USD 40 mn | 0.7% | USD 79 mn | 7.0% |
| 20 | Singapore | USD 40 mn | 0.7% | USD 99 mn | 9.5% |
| 21 | Russia | USD 30 mn | 0.5% | USD 60 mn | 7.3% |
| 22 | Turkey | USD 30 mn | 0.5% | USD 74 mn | 9.6% |
| 23 | Israel | USD 30 mn | 0.5% | USD 60 mn | 7.3% |
| 24 | Denmark | USD 30 mn | 0.5% | USD 60 mn | 7.3% |
| 25 | Poland | USD 30 mn | 0.5% | USD 60 mn | 7.3% |
| Rest of world | USD 257 mn | 4.5% | USD 526 mn | 7.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Becton Dickinson
- Beckman Coulter
- Thermo Fisher Scientific
- Agilent Technologies
- Sysmex
- Merck KGaA
Group 2: Regional and specialist players
- Bio-Rad Laboratories
- Sartorius
- Miltenyi Biotec
- Sony Biotechnology
- DiaSorin
- Apogee Flow Systems
- Union Biometrica
- Mindray
Group 3: Emerging and niche players
- Cytek Biosciences
- Stratedigm
- NanoCellect Biomedical
- Cytonome/ST
- Slingshot Biosciences
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the flow cytometry market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by product, by application, by instrument technology, by end user, by parameter capacity. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the flow cytometry market?
The global flow cytometry market is estimated at USD 5.3 bn in 2025 and USD 5.7 bn in 2026.
How fast will the flow cytometry market grow?
It is forecast to reach USD 11.8 bn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 6.1 bn.
Which country is the largest market for flow cytometry?
United States is the largest market by revenue at USD 2.2 bn in 2026, 38.0% of the global total. The three largest countries together hold 58.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.2% a year from 2026 to 2036.
Which flow cytometry segment is largest?
In the by product split, Reagents and consumables is the largest segment with 52.0% of 2026 revenue.
Who are the leading flow cytometry companies?
Global leaders include Becton Dickinson, Beckman Coulter, Thermo Fisher Scientific, Agilent Technologies.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Clinical Trial SupplyUSD 5.7 bn · 9.0% CAGR
- Track and TraceUSD 5.7 bn · 9.5% CAGR
- Omega-3 SupplementsUSD 5.5 bn · 6.0% CAGR
- Cleanroom EquipmentUSD 6.0 bn · 8.0% CAGR
- Microsphere Drug DeliveryUSD 6.0 bn · 8.0% CAGR
- Sterile Single-Use Endoscopy AccessoriesUSD 5.4 bn · 7.5% CAGR
- Liquid HandlingUSD 6.0 bn · 7.5% CAGR
- Tissue EngineeringUSD 6.0 bn · 10.5% CAGR